[PDF] Top 20 The effect of age on the response to the pneumococcal polysaccharide vaccine
Has 10000 "The effect of age on the response to the pneumococcal polysaccharide vaccine" found on our website. Below are the top 20 most common "The effect of age on the response to the pneumococcal polysaccharide vaccine".
The effect of age on the response to the pneumococcal polysaccharide vaccine
... Methods Subjects and Sera Collection The study group consisted of subjects over 65 years of age and the control group included subjects under the age of 45 years. The subjects in both age groups were ... See full document
8
VH3 Antibody Response to Immunization with Pneumococcal Polysaccharide Vaccine in Middle-Aged and Elderly Persons
... 2010 Pneumococcal disease continues to cause substantial morbidity and mortality among the ...protective effect of the pneumococcal polysaccharide vaccine (PPV) seems to cease as early ... See full document
5
Effect of the adult pneumococcal polysaccharide vaccine on cardiovascular disease: a systematic review and meta-analysis
... Major limitations of this meta-analysis included signi fi - cant heterogeneity between studies and varying quality of individual observational studies. The follow-up time varied from 90 days to several years among the ... See full document
9
Pneumococcal Nasopharyngeal Carriage following Reduced Doses of a 7-Valent Pneumococcal Conjugate Vaccine and a 23-Valent Pneumococcal Polysaccharide Vaccine Booster
... In conclusion, although the sample size was small, there appeared to be a PCV dose effect on VT carriage, with less VT carriage occurring with more doses of PCV. A single PCV dose resulted in some initial ... See full document
7
A case series evaluating the serological response of adult asthma patients to the 23-valent pneumococcal polysaccharide vaccine
... serological response to PPSV23 in a case series of patients with moderate to severe ...the age of forty, three had a smoking history of only 3–4 pack years and all 4 had no evidence of COPD on pulmonary ... See full document
9
Is the 23-valent pneumococcal polysaccharide vaccine useful in preventing community-acquired pneumonia?
... hospitalization, age, sex and underlying diseases that could influence the disease ...confounding effect of these variables, we adjusted the results using conditional logistic ...confounding effect ... See full document
19
Economic Evaluation of Immunisation Programme of 23-Valent Pneumococcal Polysaccharide Vaccine and the Inclusion of 13-Valent Pneumococcal Conjugate Vaccine in the List for Single-Dose Subsidy to the Elderly in Japan
... uptake vaccine through these extra programmes, the strategy will move from current PPSV–23 strategy towards 65 PPSV –23 strategy and these results will be useful for those ...of pneumococcal diseases and ... See full document
17
Effect of Combined Pneumococcal Conjugate and Polysaccharide Vaccination on Recurrent Otitis Media With Effusion
... the effect of combined pneumococcal conjugate and polysaccharide vaccinations on the recurrence of ...of age, with documented persistent bilateral ...7-valent pneumococcal conjugate ... See full document
8
Inhaled delivery of 23-valent pneumococcal polysaccharide vaccine does not result in enhanced pulmonary mucosal immunoglobulin responses
... the age, gender distribution or FEV1 of the ...injected vaccine had a lower mean BAL recovery volume at both bronchoscopies than the group randomized to receive inhaled ...pro-inflammatory effect of ... See full document
14
The 23 valent pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis: a double blinded, randomized, placebo controlled trial
... of age should receive PPSV23 and began pro- moting routine vaccination with ...In response to this public comment, the NHO central IRB recom- mended stopping this trial continuation and vaccination with ... See full document
10
Priming of Immunological Memory by Pneumococcal Conjugate Vaccine in Children Unresponsive to 23-Valent Polysaccharide Pneumococcal Vaccine
... of age are regarded as relatively immature, which finds its expression also in vaccination strategies ...of age and older than 5 ...a pneumococcal conjugate vaccine had previously also been ... See full document
7
Policy Statement: Recommendations for the Prevention of Pneumococcal Infections, Including the Use of Pneumococcal Conjugate Vaccine (Prevnar), Pneumococcal Polysaccharide Vaccine, and Antibiotic Prophylaxis
... 23PS vaccine for certain chil- dren 60 months or ...any age, particularly children at high risk for invasive pneumococcal in- fection, is not ...23PS vaccine is ... See full document
7
Serotype-Specific and Age-Dependent Generation of Pneumococcal Polysaccharide-Specific Memory B-Cell and Antibody Responses to Immunization with a Pneumococcal Conjugate Vaccine
... of age, but vaccine-induced antibody levels in this age group wane ...heptavalent pneumococcal conjugate vaccine to determine differences in B-cell and antibody ...a pneumococcal ... See full document
12
Outer Membrane Protein Complex of Meningococcus Enhances the Antipolysaccharide Antibody Response to Pneumococcal Polysaccharide–CRM197 Conjugate Vaccine
... after pneumococcal conjugate-plus-OMPC immu- nization were most pronounced in the one to two weeks im- mediately postimmunization and were less pronounced four to six weeks ...Hib-OMPC vaccine, where ... See full document
6
Effectiveness of the 23 valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older
... to vaccine serotypes) related with pneumococcal vaccination in ...addition, vaccine effectiveness was estimated adjusting for important cov- ariables such as age, underlying conditions and ... See full document
8
Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older
... (unconjugated) polysaccharide vaccine is most notable when comparing the OPA responses after 2 doses of PCV13 with those following 2 doses of ...older age group and statistically significantly greater ... See full document
9
Safety of a 13 Valent Pneumococcal Conjugate Vaccine in Elderly Adults Previously Immunized with a 23 Valent Pneumococcal Polysaccharide Vaccine: An Open Label Trial
... 2.7. Comparison with Other PCV13 Studies Two other studies in the PCV13 clinical development program had enrolled subjects of similar age groups. One study (study 3005) assessed the safety and immuno- genicity of ... See full document
7
Recommendations for the Prevention of Streptococcus pneumoniae Infections in Infants and Children: Use of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and Pneumococcal Polysaccharide Vaccine (PPSV23)
... PCV13 vaccine, which were approved by the Advisory Committee on Immunization Practices of the Centers for Disease Control and ...of age and for chil- dren at high risk through 71 months of ...of age ... See full document
7
Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against vaccine serotype pneumococcal pneumonia in adults: A case-control test-negative design study
... were age, sex, flu vaccination status in the past year, and clinical at-risk groups defined in accordance with Pub- lic Health England’s ‘Immunisation against Infectious Diseases’ (The Green Book) [ 3 ...(i) ... See full document
17
Prevention of pneumococcal disease among infants and children: use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine : recommendations of the Advisory Committee on Immunization Practices (ACIP)
... pack- age insert (9) although they were not observed in the PCV13 clinical trials: hypotonic-hyporesponsive episode, apnea, ana- phylactic/anaphylactoid reaction including shock, angioneu- rotic edema, erythema ... See full document
24
Related subjects